# Kidney Foundation of Canada

**Type:** Funders  
**Canonical URL:** https://scholariq.org/funders/kidney-foundation-of-canada/

## Facts

| Field | Value |
| --- | --- |
| Country | CA |
| OpenAlex ID | https://openalex.org/F4320319947 |
| ROR ID | https://ror.org/019a0gk53 |
| Works | 1,742 |

## Funder papers

- [Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups](https://scholariq.org/papers/canagliflozin-and-cardiovascular-and-renal-outcomes-in-type-2-diabetes-mellitus/)
- [Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial](https://scholariq.org/papers/canagliflozin-and-kidney-related-adverse-events-in-type-2-diabetes-and-ckd/)
- [Spironolactone versus placebo in patients undergoing maintenance dialysis (ACHIEVE): an international, parallel-group, randomised controlled trial](https://scholariq.org/papers/spironolactone-versus-placebo-in-patients-undergoing-maintenance-dialysis/)
- [Efficacy and Safety of Sotagliflozin in Patients with Type 1 Diabetes and CKD](https://scholariq.org/papers/efficacy-and-safety-of-sotagliflozin-in-patients-with-type-1-diabetes-and-ckd/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.